NAT2 (NM_000015) Human Recombinant Protein
CAT#: TP761755
Purified recombinant protein of Human N-acetyltransferase 2 (arylamine N-acetyltransferase) (NAT2), full length, with N-terminal His tag, expressed in E. coli, 50ug
Other products for "NAT2"
Specifications
Product Data | |
Species | Human |
Expression Host | E. coli |
Expression cDNA Clone or AA Sequence |
A DNA sequence encoding human full-length NAT2
|
Tag | N-His |
Predicted MW | 33.4 kDa |
Concentration | >50 ug/mL as determined by microplate BCA method |
Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | 50mM Tris, pH8.0,8M Urea. |
Storage | Store at -80°C. |
Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Reference Data | |
RefSeq | NP_000006 |
Locus ID | 10 |
UniProt ID | P11245, A4Z6T7 |
Cytogenetics | 8p22 |
Refseq Size | 1317 |
Refseq ORF | 870 |
Synonyms | AAC2; NAT-2; PNAT |
Summary | This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second arylamine N-acetyltransferase gene (NAT1) is located near this gene (NAT2). [provided by RefSeq, Jul 2008] |
Protein Families | Transmembrane |
Protein Pathways | Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways |
Documents
FAQs |
Resources
Recombinant Protein Resources |
{0} Product Review(s)
0 Product Review(s)
Submit review
Be the first one to submit a review
Product Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.